Icrucumab Uses, Dosage, Side Effects and more
Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).
| Trade Name | Icrucumab |
| Generic | Icrucumab |
| Icrucumab Other Names | Icrucumab, IMC-18F1 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
